Skip to main content
Contact Us
Subscribe
E-Edition
89°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Passage Bio Inc
(NQ:
PASG
)
0.6810
-0.0190 (-2.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Passage Bio Inc
< Previous
1
2
3
4
5
Next >
Recap: Passage Bio Q3 Earnings
November 13, 2023
Via
Benzinga
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
November 13, 2023
From
Passage Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
November 03, 2023
Via
Benzinga
Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference
October 30, 2023
From
Passage Bio
Via
GlobeNewswire
Recap: Passage Bio Q1 Earnings
May 11, 2023
Via
Benzinga
Passage Bio's Earnings: A Preview
March 03, 2023
Via
Benzinga
Expert Ratings for Passage Bio
December 15, 2022
Via
Benzinga
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 20, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
September 25, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
August 07, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study
August 07, 2023
From
Passage Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
August 03, 2023
Via
Benzinga
Passage Bio to Participate in Upcoming Investor Conferences
August 01, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors
July 31, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio And 2 Other Penny Stocks Insiders Are Aggressively Buying
June 30, 2023
The Dow Jones closed higher by over 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 15, 2023
On Thursday, 64 companies achieved new lows for the year.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 14, 2023
On Wednesday, 33 stocks hit new 52-week lows.
Via
Benzinga
Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference
June 05, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
May 11, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 21, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 17, 2023
From
Passage Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
April 03, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 27, 2023
On Monday, 89 stocks made new 52-week lows.
Via
Benzinga
Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
March 27, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights
March 06, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present at Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023
February 27, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023
February 24, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio to Present Updated Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023
February 15, 2023
From
Passage Bio
Via
GlobeNewswire
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2023
From
Passage Bio
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.